Avodart
Composition 1
The active component of Avodart is the 5-alpha-reductase dutasteride. Each capsule contains 0.5 mg of dutasteride.
Dutasteride:
Indication 1
Avodart is indicated for the treatment and control of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to improve symptoms, reduce the risk of urinary retention, and reduce the risk of the need for BPH-related surgery.
Trade marks are owned by or licensed to the GSK group of companies.
©2021 GSK group of companies or its licensor.